Panacea Biotec Faces Trading Volatility Amid Increased Investor Participation and Sector Resilience
Panacea Biotec Ltd, a small-cap pharmaceutical company, faced notable trading activity, hitting its lower circuit limit and closing at Rs 443.35. The stock showed resilience by trading above various moving averages, while investor participation increased, indicating heightened interest amid the volatility typical of small-cap stocks.
Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today, hitting its lower circuit limit. The stock closed at Rs 443.35, reflecting a decline of Rs 8.80 or 1.95%. The stock's performance was marked by a low price of Rs 429.55, which contributed to its circuit limit status.Throughout the trading session, Panacea Biotec reached an intraday high of Rs 466.55, representing a 5% price band. The total traded volume was approximately 2.19 lakh shares, resulting in a turnover of Rs 9.76 crore. Despite the day's challenges, the stock outperformed its sector, which gained 3.59%, and showed resilience by trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
Investor participation also saw a rise, with delivery volume increasing by 6.66% compared to the 5-day average. Overall, Panacea Biotec's performance today reflects the volatility often seen in small-cap stocks, with the market closely monitoring its movements in the context of broader industry trends.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
